Wikidata:Database reports/Constraint violations/P924
Jump to navigation
Jump to search
Constraint violations report for possible treatment (Discussion, uses, items, changes, related properties): health treatment used to resolve or ameliorate a medical condition
Data time stamp: (UTC) — Items processed: 354
The report is generated based on the settings on Property:P924#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
Data time stamp: (UTC) — Items processed: 354
The report is generated based on the settings on Property:P924#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
"Type health problem (Q2057971), fictional medical condition (Q18596079)" violations[edit]
Violations count: 37
- LGBT (Q17884): community (Q177634), group of humans (Q16334295), minority group (Q30103), LGBT slang (Q2537421), acronym (Q101244), matter (Q26256810), sexual minority (Q589656), gender minority (Q11894636)
- rose hip (Q46740): pome (Q41274), natural food (Q6980681), type of fruit (Q28149961), accessory fruit (Q147545)
- circumcision (Q83345): ablation (Q1886589), genital modification (Q3309852), medical procedure (Q796194), removal (Q23009442)
- transsexualism (Q190965): gender identity (Q48264), gender expression (Q15404978), physiological condition (Q7189713), gender non-conformity (Q4135211)
- Simona Halep (Q230156): human (Q5)
- convulsion (Q852376): symptom or sign (Q112965645), clinical sign (Q1441305), neurological symptom (Q12040808)
- hitting the wall (Q1567709): sports terminology (Q28829877), medical finding (Q639907), fatigue (Q9690)
- Kensuke's Kingdom (Q3226700): literary work (Q7725634)
- cancer pain (Q3712728): pain (Q81938), cancer signs and symptoms (Q5031452)
- dental anesthesia (Q5259400): anaesthesia (Q131130)
- Um as-Sibyan (Q6417777): jinn (Q3465), Spirit in Islam (Q125470220), Shaitan (Q3959257), Marid (Q212403), Ifrit (Q936678)
- Palatoplasia (Q7126848):
- Wartburg retirement community (Q7773620): retirement community (Q1269448), nonprofit organization (Q163740), assisted living facility (Q315412)
- Burzynski Clinic (Q15178216): clinic (Q1774898)
- Dautrey Procedure (Q18648693):
- benzene exposure (Q21167939): chemical hazard (Q21167512), hazardous chemical exposure (Q68182219)
- phenacyl chloride exposure (Q21173555): chemical hazard (Q21167512), hazardous chemical exposure (Q68182219)
- cyanogen chloride exposure (Q21174113): chemical hazard (Q21167512), hazardous chemical exposure (Q68182219)
- ethylene glycol exposure (Q21174292): chemical hazard (Q21167512), hazardous chemical exposure (Q68182219)
- hydrogen fluoride exposure (Q21174755): chemical hazard (Q21167512), hazardous chemical exposure (Q68182219)
- phosphine exposure (Q21175052): chemical hazard (Q21167512), hazardous chemical exposure (Q68182219)
- abrin exposure (Q21281647): biological hazard (Q864360)
- arsenic pentoxide exposure (Q21396183): chemical hazard (Q21167512), hazardous chemical exposure (Q68182219)
- lewisite exposure (Q21504975): chemical hazard (Q21167512), hazardous chemical exposure (Q68182219)
- exposure to mustard–lewisite mixture (Q21505396): chemical hazard (Q21167512), lewisite exposure (Q21504975), hazardous chemical exposure (Q68182219)
- ricin exposure (Q21515358): chemical hazard (Q21167512), hazardous chemical exposure (Q68182219)
- sulfur mustard exposure (Q21973551): chemical hazard (Q21167512)
- IPERGAY (Q28402038): clinical trial (Q30612)
- post-exertional malaise (Q42417507): symptom (Q169872), clinical sign (Q1441305)
- Home Oxygen Treatment of Childhood Acute Bronchiolitis (Q64644831): clinical trial (Q30612)
- Q65240998: compression stockings (Q745049)
- WALANT (Q65598518):
- identity alteration (Q96470164): symptom (Q169872), condition (Q813912), physiological condition (Q7189713)
- high risk student (Q106471495): student (Q48282), high risk group (Q106471130)
- Bytox Hangover Patch (Q110517193):
- Douglas fir resin (Q112588281): natural resin (Q37933789)
- LSTA1 (Q125556683):
Types statistics[edit]
"Entity types" violations[edit]
Violations count: 0
"Scope" violations[edit]
Violations count: 60
- IV Drip Clinic (Q121888447): instance of (P31): clinic (Q1774898)
- Mike Smith (Q6848867): cause of death (P509): complication (Q1346149)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): electrolyte imbalance (Q1326943)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): hemolysis (Q471706)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): oliguria (Q961326)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): kidney failure (Q476921)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): restlessness (Q10649843)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): irritability (Q29299)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): headache (Q86)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): mental confusion (Q557945)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): memory loss (Q989365)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): personality change (Q3525894)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): hallucination (Q130741)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): Delirium (Q160796)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): convulsion (Q852376)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): coma (Q159557)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): deafness (Q12133)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): peripheral neuropathy (Q945238)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): pain agnosia (Q2868696)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): weight loss (Q718113)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): anorexia (Q254327)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): leukopenia (Q496812)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): anemia (Q5445)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): thrombocytopenia (Q585285)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): baldness (Q181391)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): blister (Q276469)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): itch (Q199602)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): rash (Q653197)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): exfoliation (Q1124872)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): Mees' lines (Q1567863)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): cough (Q35805)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): hemoptysis (Q647099)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): chest pain (Q693058)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): pulmonary edema (Q857667)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): respiratory failure (Q767485)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): heart arrhythmia (Q189331)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): hypotension (Q275419)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): kidney disease (Q1054718)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): miscarriage (Q28693)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): stillbirth (Q745832)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): skin cancer (Q192102)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): lung cancer (Q47912)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): bladder cancer (Q504775)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): liver cancer (Q623031)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): sensory peripheral neuropathy (Q18555098)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): peripheral artery disease (Q378681)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): asthenia (Q633403)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): malaise (Q2673323)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): anorexia (Q254327)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): hepatomegaly (Q1362864)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): jaundice (Q133244)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): gastrointestinal system disease (Q2300099)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): conjunctivitis (Q167844)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): respiratory irritation (Q21112283)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): nasal septal perforation (Q3899830)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): dermatitis (Q229256)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): depigmentation (Q3705665)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): hyperkeratosis (Q1640998)
- arsenic pentoxide exposure (Q21396183): has effect (P1542): tear secretion (Q12153824)
- Jod-Basedow phenomenon (Q1636323): health specialty (P1995): endocrinology (Q162606)